Eric Lefkofsky Has A Mission To Match Cancer Patients And Appropriate Treatments

The medical and technology communities have perfect opportunities to combine resources to combat common maladies. Cancer, and the presence of tumors, is one realm of human sickness that can be addressed with the amazing power of technological innovation and medical ingenuity.

Tempus is a cancer research and practice business start-up that aims to direct the most cutting-edge imaging and diagnostic software to the labs and offices of doctors treating cancer. Its goal is to create a situation where each cancer patient has the opportunity to be categorized according to individual need. This results in a highly individualized approach to treating specific cancer needs.

Eric Lefkofsky’s idea for a channel that personalizes cancer tumor treatment is absolutely innovative. It contrasts the assembly line method that the world’s medical community sometimes takes when treating people with specific cancer concerns. The need for treatment of specific tumors is immense, and it far outpaces the results of research. Lefkofsky’s start-up has the goal of directing specific treatments to individual needs. This involves experimental tumor treatments and a pinpointed, specific brand of cancer care.

Tempus is unlike any other patient-to-doctor catalyst because it emphasizes the need for individualized treatment protocols over mass medical schedules. Eric Lefkofsky has an extensive background in bringing technology to an eager market. Now, his interests are helping to bolster the medical community in the realm of cancer treatment.

The Tempus model is focused on matching cancer patients with specific treatments much like a specific brand is matched with a niche market. Complex analytical tools relay information about a patient’s individual tumor configurations and cancer diagnoses to specific treatment types and doctor specialties. This type of advance eliminates much of the stress searching patients must endure to find the right clinic, research facility, doctor, and ultimate treatment for their needs.

Eric Lefkofsky has an intimate understanding of what a cancer patient faces when seeking medical care. There is an extraordinary amount of testing and time required to match patients with the doctors and facilities that can best address their type of sickness. This time lag often results in a poor outlook. Minimizing the time it takes to find appropriate care using analytical tools is a welcomed advance in the pre-operative cancer world. Tempus is a bridge between aggressive treatment and the stress of dealing with a cancer diagnosis.

Learn more about Eric Lefkofsky at www.forbes.com/profile/eric-lefkofsky